Witamin D in children population - benefits and threats
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.056Keywords
suplementation witamin D in children, hypercalcemia, rickets in children, vitamin D deficiencyAbstract
Introduction
Nowadays, it has become fashionable to use dietary supplements containing large doses of vitamin D available without a prescription. In the case of children, dietary supplementation with a properly selected dose of vitamin D is extremely important and brings many benefits, of which it is important to prevent rickets in the pediatric population, attention is also drawn to its toxicity and consequences in the event of an overdose of vitamin D preparations, to which infants and young children are most exposed, examples of risks are hypercalcemia, hypercalciuria and nephrocalcinosis.
The aim of the study
Showing the benefits and dangers of vitamin D supplementation.
Material and methods
The research was conducted using PubMed articles and on: vitamin D supplementation in children, vitamin D overdose, vitamin D deficiency.
Description of the state of knowledge
Vitamin D is the generic name for ergocalciferol and cholecalciferol that we can find in foods, however, food and supplementation are not its only sources, it should be borne in mind that it is possible to synthesize vitamin D in the skin after exposure to ultraviolet reproduction (UV-B). The concentration of 25(OH)D in childhood serum is influenced by the amount and frequency of vitamin D consumed, sun exposure, body weight and body fat levels. The main risk of vitamin D deficiency in children is rickets and defromation of the osteoarticular system and metabolic disorders, and long-term use of its high doses can lead to hypercalcemia and nephrocalcinosis.
Summary
It is very important to educate parents about the importance of vitamin D supplementation in a dose properly selected for the newborn along with an explanation of the possible consequences of deficiency, as well as overdose.
References
Mailhot G, Biały JH. Witamina D i odporność u niemowląt i dzieci. Składników odżywczych. 2020 kwiecień 27;12(5):1233. doi: 10.3390/nu12051233. PMID: 32349265; PMCID: PMC7282029.
Holick, M.F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18, 153–165 (2017). https://doi.org/10.1007/s11154-017-9424-1
Souberbielle JC, Maruani G, Courbebaisse M. Vitamine D: métabolisme et évaluation des réserves [Metabolizm i główne działanie witaminy D]. Presse Med. 2013 Oct;42(10):1343-50. Francuski. doi: 10.1016/j.lpm.2013.07.010. Epub 2013 17 września. PMID: 24051166.
Holick MF. Filogenetyczne i ewolucyjne aspekty witaminy D od fitoplanktonu do ludzi. W: Pang PKT, poseł Schreibman. Red. Endokrynologia kręgowców: podstawy i implikacje biomedyczne. Tom 3. Orlando, Floryda: Academic Press, Inc (Harcourt Brace Jovanovich),1989:7–43.
Holick MF. Witamina D: Perspektywa milenijna. J Cell Biochem 2003; 88:296–307.
Holick MF, Garabedian M Vitamin D. photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ. ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th ed. Washington, DC: American Society for Bone and Mineral Research, 2006:129–37.
Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662–87.
Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 2002;8:174–9.
Ketha H, Wadams H, Lteif A, Singh RJ. Jatrogenna toksyczność witaminy D u niemowlęcia - opis przypadku i przegląd literatury. J Steroid Biochem Mol Biol. 2015 Kwiecień; 148: 14-8. doi: 10.1016/j.jsbmb.2015.01.022. Epub 2015 27 stycznia. PMID: 25636720.
Panel EFSA ds. produktów dietetycznych, żywienia i alergii (panel EFSA NDA), Turck D, Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Nowicka G, Pentieva K, Sanz Y, Siani A, Sjödin A, Stern M, Tomé D, Loveren HV, Vinceti M, Willatts P, Fewtrell M, Lamberg-Allardt C, Przyrembel H, Arcella D, Dumas C, Fabiani L, Martino L, Tomcikova D, Neuhäuser-Berthold M. Aktualizacja tolerowanego górnego poziomu spożycia witaminy D dla niemowląt. EFSA J. 2018 Aug 7;16(8):e05365. doi: 10.2903/j.efsa.2018.5365. PMID: 32626014; PMCID: PMC7009676.
Vieth R. Suplementacja witaminy D: cholekalcyferol, kalcyfediol i kalcytriol. Eur J Clin Nutr. 2020 listopada;74(11):1493-1497. doi: 10.1038/s41430-020-0697-1. Epub 2020 23 lipca. PMID: 32704098.
Płudowski P., Kaczmarewicz E. i wsp.: Wytyczne suplementacji witaminą D dla Europy Środkowej: Rekomendowane dawki witaminy D dla populacji zdrowej oraz dla grup ryzyka deficytu witaminy D. Endokrynol. Pol. 2013; 64 (4).
Bartley J. Witamina D: pojawiające się role w infekcji i odporności. Ekspert Rev Anti Infect Ther. 2010 grudzień;8( 12):1359-69. doi: 10.1586/eri.10.102. PMID: 21133662.
Joanna Walczyk; Wytyczne suplementacji witaminy D – skrót aktualnych zaleceń, Medycyna Praktyczna 2013.
Gurkan F, Davutoglu M, Bosnak M, et al. Pamidronate treatment in acute vitamin D intoxication, J Endocrinol Invest, 2004, vol. 27 (pg. 680-2)
Joshi R. Hiperkalcemia z powodu hiperwitaminozy D: raport siedmiu pacjentów. J Trop Pediatr. 2009 Grudzień;55(6):396-8. doi: 10.1093/tropej/fmp020. Epub 2009 1 kwietnia. PMID: 19339514.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Justyna Wójcik-Grudzień, Alicja Ozga-Stachurska, Paulina Pawłowska, Martyna Rozenbajgier

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 432
Number of citations: 0